An Extension Study of PEAK Trial

NCT02763007 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

41

Enrollment

OTHER

Sponsor class

Stopped difficulty in recruiting patients

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: alogliptin+pioglitazone
DRUG: alogliptin
DRUG: pioglitazone

Sponsor

Kun-Ho Yoon

Collaborators

[object Object]